- Home
- OBA vs CLLS Comparison
OBA vs CLLS Comparison
Compare OBA & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBA
- CLLS
- Stock Information
- Founded
- OBA 2024
- CLLS 1999
- Country
- OBA Canada
- CLLS France
- Employees
- OBA N/A
- CLLS N/A
- Industry
- OBA
- CLLS Biotechnology: Pharmaceutical Preparations
- Sector
- OBA
- CLLS Health Care
- Exchange
- OBA Nasdaq
- CLLS Nasdaq
- Market Cap
- OBA 314.7M
- CLLS 299.0M
- IPO Year
- OBA 2025
- CLLS 2007
- Fundamental
- Price
- OBA $9.96
- CLLS $3.79
- Analyst Decision
- OBA
- CLLS Buy
- Analyst Count
- OBA 0
- CLLS 1
- Target Price
- OBA N/A
- CLLS $4.00
- AVG Volume (30 Days)
- OBA 27.5K
- CLLS 151.7K
- Earning Date
- OBA 01-01-0001
- CLLS 11-03-2025
- Dividend Yield
- OBA N/A
- CLLS N/A
- EPS Growth
- OBA N/A
- CLLS N/A
- EPS
- OBA N/A
- CLLS N/A
- Revenue
- OBA N/A
- CLLS $63,438,000.00
- Revenue This Year
- OBA N/A
- CLLS N/A
- Revenue Next Year
- OBA N/A
- CLLS $66.76
- P/E Ratio
- OBA N/A
- CLLS N/A
- Revenue Growth
- OBA N/A
- CLLS 223.09
- 52 Week Low
- OBA $9.93
- CLLS $1.10
- 52 Week High
- OBA $9.97
- CLLS $3.83
- Technical
- Relative Strength Index (RSI)
- OBA N/A
- CLLS 65.98
- Support Level
- OBA N/A
- CLLS $3.36
- Resistance Level
- OBA N/A
- CLLS $3.60
- Average True Range (ATR)
- OBA 0.00
- CLLS 0.24
- MACD
- OBA 0.00
- CLLS 0.02
- Stochastic Oscillator
- OBA 0.00
- CLLS 96.95
About OBA Oxley Bridge Acquisition Limited Class A Ordinary Shares
Oxley Bridge Acquisition Ltd is a blank check company.
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.